{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T02:54:37Z","timestamp":1791946477240,"version":"4.3.4"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,8,26]],"date-time":"2024-08-26T00:00:00Z","timestamp":1724630400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100010983","name":"Health Research Foundation of Central Denmark Region","doi-asserted-by":"publisher","award":["R86-A4065-B2327"],"award-info":[{"award-number":["R86-A4065-B2327"]}],"id":[{"id":"10.13039\/501100010983","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005940","name":"Danish Cancer Research Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005940","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008363","name":"Danish Cancer Society","doi-asserted-by":"publisher","award":["R302-A17275"],"award-info":[{"award-number":["R302-A17275"]}],"id":[{"id":"10.13039\/100008363","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008363","name":"Danish Cancer Society","doi-asserted-by":"publisher","award":["R325-A18822"],"award-info":[{"award-number":["R325-A18822"]}],"id":[{"id":"10.13039\/100008363","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thegreenjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Radiotherapy and Oncology"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.radonc.2024.110506","type":"journal-article","created":{"date-parts":[[2024,8,26]],"date-time":"2024-08-26T18:51:47Z","timestamp":1724698307000},"page":"110506","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["Daily CBCT-based dose calculations for enhancing the safety of dose-escalation in lung cancer radiotherapy"],"prefix":"10.1016","volume":"200","author":[{"given":"S.N.","family":"Thomsen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.S.","family":"M\u00f8ller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.M.","family":"Knap","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.A.","family":"Khalil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Shcytte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Hoffmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.radonc.2024.110506_b0005","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3322\/caac.21551","article-title":"Cancer statistics, 2019","volume":"69","author":"Siegel","year":"2019","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.radonc.2024.110506_b0010","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1200\/JCO.2009.26.2543","article-title":"Meta-analysis of concomitant versus sequential radiochemotherapy in locally advanced non-small-cell lung cancer","volume":"28","author":"Aup\u00e9rin","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2024.110506_b0015","doi-asserted-by":"crossref","first-page":"336","DOI":"10.3109\/0284186X.2013.868035","article-title":"Pattern of loco-regional failure after definitive radiotherapy for non-small cell lung cancer","volume":"53","author":"Schytte","year":"2014","journal-title":"Acta Oncol"},{"key":"10.1016\/j.radonc.2024.110506_b0020","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.radonc.2017.03.017","article-title":"A randomized phase II trial of concurrent chemoradiation with two doses of radiotherapy, 60Gy and 66Gy, concomitant with a fixed dose of oral vinorelbine in locally advanced NSCLC","volume":"123","author":"Hansen","year":"2017","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2024.110506_b0025","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.radonc.2022.01.039","article-title":"Survival benefits for non-small cell lung cancer patients treated with adaptive radiotherapy","volume":"168","author":"M\u00f8ller","year":"2022","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2024.110506_b0030","article-title":"Accelerated hypofractionated chemoradiation followed by stereotactic ablative radiotherapy boost for locally advanced, unresectable non-small cell lung cancer: A nonrandomized controlled trial","volume":"11","author":"Wu","year":"2024","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.radonc.2024.110506_b0035","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1186\/s12885-021-09099-3","article-title":"Dose-escalation by hypofractionated simultaneous integrated boost IMRT in unresectable stage III non-small-cell lung cancer","volume":"22","author":"Zhang","year":"2022","journal-title":"BMC Cancer"},{"key":"10.1016\/j.radonc.2024.110506_b0040","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/j.ijrobp.2019.11.397","article-title":"Long-term results from the IDEAL-CRT phase 1\/2 trial of isotoxically dose-escalated radiation therapy and concurrent chemotherapy for stage II\/III non-small cell lung cancer","volume":"106","author":"Fenwick","year":"2020","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2024.110506_b0045","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1001\/jamaoncol.2017.0982","article-title":"Effect of midtreatment PET\/CT-adapted radiation therapy with concurrent chemotherapy in patients with locally advanced non-small-cell lung cancer: A phase 2 clinical trial","volume":"3","author":"Kong","year":"2017","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.radonc.2024.110506_b0050","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.radonc.2018.09.019","article-title":"The acute and late toxicity results of a randomized phase II dose-escalation trial in non-small cell lung cancer (PET-boost trial)","volume":"131","author":"van Diessen","year":"2019","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2024.110506_b0055","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S1470-2045(14)71207-0","volume":"16","author":"Bradley","year":"2015","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.radonc.2024.110506_b0060","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.jtho.2023.01.085","article-title":"Demystifying the results of RTOG 0617: Identification of dose sensitive cardiac subregions associated with overall survival","volume":"18","author":"McWilliam","year":"2023","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.radonc.2024.110506_b0065","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1200\/JCO.2016.69.1378","article-title":"Impact of intensity-modulated radiation therapy technique for locally advanced non-small-cell lung cancer: A secondary analysis of the NRG Oncology RTOG 0617 randomized clinical trial","volume":"35","author":"Chun","year":"2017","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2024.110506_b0070","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1200\/JCO.19.01162","article-title":"Long-term results of NRG Oncology RTOG 0617: Standard- versus high-dose chemoradiotherapy with or without cetuximab for unresectable stage III non-small-cell lung cancer","volume":"38","author":"Bradley","year":"2020","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2024.110506_b0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2023.109492","article-title":"18F-FDG-PET guided vs whole tumour radiotherapy dose escalation in patients with locally advanced non-small cell lung cancer (PET-Boost): Results from a randomised clinical trial","volume":"181","author":"Cooke","year":"2023","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2024.110506_b0080","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1016\/j.jtho.2016.03.008","article-title":"Outcomes of hypofractionated high-dose radiotherapy in poor-risk patients with \u201cUltracentral\u201d non-small cell lung cancer","volume":"11","author":"Tekatli","year":"2016","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.radonc.2024.110506_b0085","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1016\/j.jtho.2021.03.019","article-title":"The HILUS-trial-a prospective nordic multicenter phase 2 study of ultracentral lung tumors treated with stereotactic body radiotherapy","volume":"16","author":"Lindberg","year":"2021","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.radonc.2024.110506_b0090","doi-asserted-by":"crossref","first-page":"4343","DOI":"10.1200\/JCO.2013.51.5353","article-title":"Dose-limiting toxicity after hypofractionated dose-escalated radiotherapy in non-small-cell lung cancer","volume":"31","author":"Cannon","year":"2013","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2024.110506_b0095","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1080\/09553002.2019.1552375","article-title":"Is stereotactic body radiotherapy for ultra-central lung tumor a feasible option? A systemic review and meta-analysis","volume":"95","author":"Rim","year":"2019","journal-title":"Int J Radiat Biol"},{"key":"10.1016\/j.radonc.2024.110506_b0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2023.109848","article-title":"Ten years outcomes after SABR in central and ultracentral primary lung tumors","volume":"188","author":"Tekatli","year":"2023","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2024.110506_b0105","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.radonc.2017.06.022","article-title":"Heterogeneous FDG-guided dose-escalation for locally advanced NSCLC (the NARLAL2 trial): Design and early dosimetric results of a randomized, multi-centre phase-III study","volume":"124","author":"M\u00f8ller","year":"2017","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2024.110506_b0110","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1080\/0284186X.2017.1366049","article-title":"The NARLAL2 dose escalation trial: Dosimetric implications of inter-fractional changes in organs at risk","volume":"57","author":"Hoffmann","year":"2018","journal-title":"Acta Oncol"},{"key":"10.1016\/j.radonc.2024.110506_b0115","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1080\/0284186X.2017.1373848","article-title":"Difference in target definition using three different methods to include respiratory motion in radiotherapy of lung cancer","volume":"56","author":"Sloth M\u00f8ller","year":"2017","journal-title":"Acta Oncol"},{"key":"10.1016\/j.radonc.2024.110506_b0120","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.ijrobp.2005.05.045","article-title":"Use of maximum intensity projections (MIP) for target volume generation in 4DCT scans for lung cancer","volume":"63","author":"Underberg","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2024.110506_b0125","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.semradonc.2009.11.003","article-title":"Adaptive radiotherapy for lung cancer","volume":"20","author":"Sonke","year":"2010","journal-title":"Semin Radiat Oncol"},{"key":"10.1016\/j.radonc.2024.110506_b0130","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.radonc.2016.08.019","article-title":"Adaptive radiotherapy for advanced lung cancer ensures target coverage and decreases lung dose","volume":"121","author":"M\u00f8ller","year":"2016","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2024.110506_b0135","doi-asserted-by":"crossref","DOI":"10.1002\/mp.13053","article-title":"Validation of the Acuros XB dose calculation algorithm versus Monte Carlo for clinical treatment plans","author":"Hoffmann","year":"2018","journal-title":"Med Phys"},{"key":"10.1016\/j.radonc.2024.110506_b0140","doi-asserted-by":"crossref","first-page":"5547","DOI":"10.1118\/1.4962934","article-title":"A robust empirical parametrization of proton stopping power using dual energy CT","volume":"43","author":"Taasti","year":"2016","journal-title":"Med Phys"},{"key":"10.1016\/j.radonc.2024.110506_b0145","doi-asserted-by":"crossref","unstructured":"Holm AIS, Nyeng TB, S M\u00f8ller D, Assenholt MS, Hansen R, Nyvang L, et al. Density calibrated cone beam CT as a tool for adaptive radiotherapy. Acta Oncol. 2021 Oct;60(10):1275-1282. doi: 10.1080\/0284186X.2021.1945678.","DOI":"10.1080\/0284186X.2021.1945678"},{"key":"10.1016\/j.radonc.2024.110506_b0150","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.phro.2018.09.001","article-title":"Cone beam CT based dose calculation in the thorax region","volume":"28","author":"Kaplan","year":"2018","journal-title":"Phys Imaging Radiat Oncol"},{"key":"10.1016\/j.radonc.2024.110506_b0155","doi-asserted-by":"crossref","unstructured":"Bobi\u0107 M, Lalonde A, Sharp GC, Grassberger C, Verburg JM, Winey BA et al. Comparison of weekly and daily online adaptation for head and neck intensity-modulated proton therapy. Phys Med Biol. 2021 Feb 25;66:10.1088\/1361-6560\/abe050. doi: 10.1088\/1361-6560\/abe050.","DOI":"10.1088\/1361-6560\/abe050"},{"key":"10.1016\/j.radonc.2024.110506_b0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2024.110214","article-title":"Baseline shift corrections towards the heart: External validation of the impact on survival in early-stage NSCLC patients","volume":"195","author":"Juan-Cruz","year":"2024","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2024.110506_b0165","doi-asserted-by":"crossref","first-page":"8548","DOI":"10.1200\/JCO.2021.39.15_suppl.8548","article-title":"NRG-RTOG 1106\/ACRIN 6697: A phase IIR trial of standard versus adaptive (mid-treatment PET-based) chemoradiotherapy for stage III NSCLC\u2014Results and comparison to NRGRTOG 0617 (non-personalized RT dose escalation)","volume":"39","author":"Kong","year":"2021","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2024.110506_b0170","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/S1470-2045(20)30013-9","article-title":"Imaging-based target volume reduction in chemoradiotherapy for locally advanced non-small-cell lung cancer (PET-Plan): A multicentre, open-label, randomised, controlled trial","volume":"21","author":"Nestle","year":"2020","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.radonc.2024.110506_b0175","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.jtho.2016.12.021","article-title":"Long-term results of a trial of concurrent chemotherapy and escalating doses of radiation for unresectable non-small cell lung cancer: NCCTG N0028 (Alliance)","volume":"12","author":"Schild","year":"2017","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.radonc.2024.110506_b0180","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.radonc.2007.07.001","article-title":"Quality assurance of dosimetry and the impact on sample size in randomized clinical trials","volume":"86","author":"Pettersen","year":"2008","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2024.110506_b0185","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.radonc.2014.10.009","article-title":"Intra thoracic anatomical changes in lung cancer patients during the course of radiotherapy","volume":"113","author":"Kwint","year":"2014","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2024.110506_b0190","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.radonc.2013.10.013","article-title":"Adaptive radiotherapy of lung cancer patients with pleural effusion or atelectasis","volume":"110","author":"M\u00f8ller","year":"2014","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2024.110506_b0195","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1016\/j.jtho.2017.03.025","article-title":"Local control and toxicity of adaptive radiotherapy using weekly CT imaging: Results from the LARTIA trial in stage III NSCLC","volume":"12","author":"Ramella","year":"2017","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.radonc.2024.110506_b0200","article-title":"Cone-beam-CT guided adaptive radiotherapy for locally advanced non-small cell lung cancer enables quality assurance and superior sparing of healthy lung","volume":"9","author":"Hoegen","year":"2020","journal-title":"Front Oncol"},{"key":"10.1016\/j.radonc.2024.110506_b0205","doi-asserted-by":"crossref","unstructured":"Mao W, Riess J, Kim J, Vance S, Chetty IJ, Movsas B, et al. Evaluation of Auto-Contouring and Dose Distributions for Online Adaptive Radiation Therapy of Patients With Locally Advanced Lung Cancers. Pract Radiat Oncol. 2022 Jul-Aug;12:e329-e338. doi: 10.1016\/j.prro.2021.12.017.","DOI":"10.1016\/j.prro.2021.12.017"},{"key":"10.1016\/j.radonc.2024.110506_b0210","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1186\/s13014-023-02258-9","article-title":"Pulmonary magnetic resonance-guided online adaptive radiotherapy of locally advanced: The PUMA trial","volume":"18","author":"Regnery","year":"2023","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.radonc.2024.110506_b0215","doi-asserted-by":"crossref","first-page":"2186","DOI":"10.1118\/1.3697524","article-title":"A stochastic approach to estimate the uncertainty of dose mapping caused by uncertainties in b-spline registration","volume":"39","author":"Hub","year":"2012","journal-title":"Med Phys"},{"key":"10.1016\/j.radonc.2024.110506_b0220","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1118\/1.3666948","article-title":"On the dosimetric effect and reduction of inverse consistency and transitivity errors in deformable image registration for dose accumulation","volume":"39","author":"Bender","year":"2012","journal-title":"Med Phys"},{"key":"10.1016\/j.radonc.2024.110506_b0225","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/1748-717X-3-42","article-title":"Investigation of the usability of conebeam CT data sets for dose calculation","volume":"16","author":"Richter","year":"2008","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.radonc.2024.110506_b0230","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.radonc.2012.06.007","article-title":"Feasibility of CBCT-based dose calculation: Comparative analysis of HU adjustment techniques","volume":"104","author":"Fotina","year":"2012","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2024.110506_b0235","doi-asserted-by":"crossref","unstructured":"Kaliyaperumal V, Raphael CJ, Varghese KM, Gopu P, Sivakumar S, Boban M, et al. Study of Variation in Dose Calculation Accuracy Between kV Cone-Beam Computed Tomography and kV fan-Beam Computed Tomography. J Med Phys. 2017 Jul-Sep;42:171-180. doi: 10.4103\/jmp.JMP_24_17.","DOI":"10.4103\/jmp.JMP_24_17"},{"key":"10.1016\/j.radonc.2024.110506_b0240","doi-asserted-by":"crossref","first-page":"20180383","DOI":"10.1259\/bjr.20180383","article-title":"An evaluation of techniques for dose calculation on cone beam computed tomography","volume":"92","author":"Giacometti","year":"2019","journal-title":"Br J Radiol"},{"key":"10.1016\/j.radonc.2024.110506_b0245","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.ejmp.2019.11.015","article-title":"Using the iterative kV CBCT reconstruction on the Varian Halcyon linear accelerator for radiation therapy planning for pelvis patients","volume":"68","author":"Jarema","year":"2019","journal-title":"Phys Med"},{"key":"10.1016\/j.radonc.2024.110506_b0250","doi-asserted-by":"crossref","first-page":"5934","DOI":"10.1118\/1.4964455","article-title":"Accuracy of dose calculations on kV cone beam CT images of lung cancer patients","volume":"43","author":"de Smet","year":"2016","journal-title":"Med Phys"}],"container-title":["Radiotherapy and Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016781402400776X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016781402400776X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,23]],"date-time":"2025-06-23T12:25:24Z","timestamp":1750681524000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S016781402400776X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":50,"alternative-id":["S016781402400776X"],"URL":"https:\/\/doi.org\/10.1016\/j.radonc.2024.110506","relation":{},"ISSN":["0167-8140"],"issn-type":[{"value":"0167-8140","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Daily CBCT-based dose calculations for enhancing the safety of dose-escalation in lung cancer radiotherapy","name":"articletitle","label":"Article Title"},{"value":"Radiotherapy and Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.radonc.2024.110506","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"110506"}}